Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carcinological risks and retroperitoneal laparoscopy.

A Cicco1, L Salomon, H Hoznek

  • 1Service d'Urologie, Hôpital Henri Mondor, Créteil, France.

European Urology
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Infections and male infertility].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

[Guidelines from the cancer committee of the French Association of Urology (CC-AFU) for adequate intravesical instillations of Mitomycin C, Epirubicin, and BCG for non-muscle invasive bladder cancer].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
Same author

[Guidelines from the cancer (CC-AFU) and infection disease (CI-AFU) committees of the French Association of Urology for the management of adverse events and complications of BCG].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
Same author

Relationship between socioeconomic status and prostate cancer (incidence, aggressiveness, treatment with curative intent, and mortality): a spatial analysis using population-based cancer registry data.

Revue d'epidemiologie et de sante publique·2021
Same author

FUrTIHF: French urinary tract infections in healthcare facilities - five-year historic cohort (2014-2018).

The Journal of hospital infection·2021
Same author

Achieving disease free distal ureteral margin at the time of radical cystectomy: Why and for whom? (an overview of literature).

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2021
Same journal

Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-sparing Therapy for Recurrent High-grade Non-muscle-invasive Bladder Cancer: Recurrent High-risk NMIBC: One Bladder, Choose Wisely.

European urology·2026
Same journal

Re: Dries Develtere, Riccardo Bertolo. Cumulative Genitourinary Toxicity After Prostate Radiotherapy: High-Level Long-Term Randomized Evidence. J Clin Oncol. Online ahead of print. http://dx.doi.org/10.1200/JCO-26-00436.

European urology·2026
Same journal

In Memory of Paul Mitrofanoff (1934-2025).

European urology·2026
Same journal

Re: McKay RR, Pal S, Xie W, et al. Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert Consensus on the Management of Renal Cell and Urinary Tract Cancers. CA Cancer J Clin 2026;76:e70052.

European urology·2026
Same journal

Re: Ultra-hypofractionated Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma: 5-year Outcomes from a Pooled Analysis of the FASTRACK Trials.

European urology·2026
Same journal

Re: Alexander D. Sherry, Van To, Criselle D'souza, et al. Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.024.

European urology·2026
See all related articles

Retroperitoneal laparoscopic surgery for upper tract malignancies shows no increased risk of port site or local recurrence. Disease-free survival rates are comparable to open surgery, making it a viable option.

Area of Science:

  • Urology
  • Surgical Oncology
  • Minimally Invasive Surgery

Background:

  • Retroperitoneal laparoscopic surgery is increasingly used for upper urinary tract malignancies.
  • Assessing oncologic outcomes, including recurrence and metastasis, is crucial for patient management.

Purpose of the Study:

  • To evaluate the incidence of trocar site spillage, local recurrence, and metastatic disease following retroperitoneal laparoscopic tumor resection.
  • To compare oncologic outcomes with historical data from open surgery.

Main Methods:

  • Retrospective review of 228 retroperitoneal laparoscopic procedures from 1994-1999.
  • Analysis of 56 procedures for malignancies (radical nephrectomies, partial nephrectomies, nephro-ureterectomies).
  • Postoperative follow-up included physical and radiological examinations; Kaplan-Meier analysis for disease-free survival.

Related Experiment Videos

Main Results:

  • No laparoscopic trocar site recurrences were observed in the study cohort.
  • Local recurrence and distant metastasis occurred in a small percentage of patients with advanced disease.
  • Disease-free survival rates at 54 months were 91% for radical nephrectomy and 61% for nephro-ureterectomy.

Conclusions:

  • Retroperitoneal laparoscopy is a safe and effective approach for managing upper urinary tract malignancies.
  • The procedure is not associated with an increased risk of port-site or local recurrence.
  • Disease-free survival outcomes appear equivalent to those achieved with traditional open surgical methods.